- Axtria Ignite 2025 Champions Life Sciences Innovation with a Focus on AI-driven transformations, Patient-Centricity, and Next-Generation Therapies
- Honoring Excellence: Ignite Leadership Awards Celebrate Trailblazing Industry Leaders Driving Impact and Paving the Path for the Industry
- Breakthrough Dialogues: 25 Impactful Sessions Spotlight the Convergence of AI, Data, and Therapeutic Innovation in the Agentic Era
Axtria Inc., an AI-first data analytics company empowering the life sciences industry, successfully hosted Axtria Ignite 2025, its flagship annual conference that brought together over 400 senior industry leaders, innovators, and changemakers on June 4-5 in Princeton, N.J.
“The life sciences industry stands at the crossroads of unprecedented transformation. At Axtria Ignite 2025, we didn’t just talk about what’s possible; we explored what’s next. From Agentic AI to patient-centric strategies, we are proud to lead this conversation and enable our clients to drive change at speed and scale,” said Jaswinder Chadha, President and CEO of Axtria. “This year’s event reflects our deep commitment to shaping a more intelligent, agile, and impactful future for healthcare.”
Axtria Ignite 2025 spotlighted three transformative themes in life sciences: new commercialization strategies for next-gen therapies like rare, orphan, cell, and gene treatments; keeping patients at the heart of operations to drive meaningful impact; and the rapid shift toward GenAI and Agentic AI, with real-world case studies revealing both successes and lessons learned.
The conference featured several sessions that were a mix of presentations, panels, workshops, and roundtables, with over 50 speakers from the world’s top life sciences companies. It included demo stations for the latest Agentic Innovations in Axtria’s products and evening receptions that sprinkled some fun along with networking.
Axtria also recognized outstanding industry leadership through its annual Ignite Leadership Award. This year’s honorees were Greg Meyers, EVP and Chief Digital and Technology Officer, Bristol Myers Squibb; Ritesh Mehra, Chief Financial Officer, Ferring Pharmaceuticals U.S.; Madhavi Ramakrishna, Senior Vice President of Enterprise AI and Chief Digital and Technology Officer for Commercial, GSK; Stephanie Odutola, Executive Director of U.S. Sales Force Operations, AstraZeneca; and Vikram Singh, Vice President and Global Head of Commercial IT Data Analytics and DSAI, Novartis.
For more information about how Axtria can support your organization's Agentic AI journey, please visit www.axtria.com.